Blaize Holdings and Winmate Inc. have formed a strategic partnership to integrate Blaize's energy-efficient AI chips into Winmate's rugged platforms, including drones, handhelds, and vehicle-mounted units used in defense, border security, maritime, and healthcare. This collaboration aims to enable real-time AI processing on devices operating in extreme environments without relying on cloud connectivity, addressing critical needs for remote and harsh settings. The companies expect to generate about $15 million in revenue in the first year and foresee a multi-year relationship to expand these edge AI solutions. This partnership targets growing demand for on-device AI in sectors requiring secure, immediate intelligence at the edge, such as border security, mobile command, and field healthcare.
Verra Mobility shares dropped 41.2% in after-hours trading following Avis Budget Group's termination of their contract effective September 2026. This contract loss could reduce Verra's annual Commercial Services revenue by $135-$145 million and segme...
Netcapital Inc. shares surged 19.63% in after-hours trading following the announcement of a business update conference call scheduled for Thursday. The new CEO, Todd Violette, will discuss the company's transformation, priorities, and plans to grow i...
ISS has secured a seven-year contract with West Sussex County Council to deliver around 25,000 nutritious school meals daily to primary schools starting Q3 2026. The contract, valued at about DKK 100 million annually, emphasizes inclusivity and high ...
TGS ASA has secured a large 4D streamer contract offshore Angola, set to begin data acquisition in early July 2026 and last about eight months. This contract strengthens TGS's strategic presence in Africa and ensures vessel utilization into early 202...
Roche has introduced the Liver Disease Panel, the first comprehensive set of certified algorithms designed to improve the detection and management of chronic liver disease (CLD). This panel includes LiverPRO, an algorithm that uses routine blood mark...
